secwatch.observer — SEC 8-K summary
======================================

Issuer:     First Tracks Biotherapeutics, Inc. (TRAX)
CIK:        0002091349
Form:       8-K
Filed at:   2026-06-22T20:05:16+00:00
Accession:  0001193125-26-277504
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

First Tracks Biotherapeutics subleases 45,057 sq ft San Diego office from AnaptysBio for 12 months
--------------------------------------------------------------------------------

- Subleased 45,057 rentable square feet at 10770 Wateridge Circle, San Diego from AnaptysBio, Inc.
- Term began June 15, 2026 for 12 months; renewal option to April 2028 or +12 months with 3-month notice.
- Monthly rent equals AnaptysBio's base rent plus additional rent under master lease, paid in advance.
- Company can terminate sublease at any time with at least 3 months' prior written notice.
- Sublease is subordinate to master lease; AnaptysBio remains liable to master landlord.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2091349/000119312526277504/0001193125-26-277504-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2091349/000119312526277504/trax-20260615.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-277504

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer